ENDONOVO THERAPEUTICS, INC. Notes and Loans Payable
ENDONOVO THERAPEUTICS, INC. (ENDV) had Notes and Loans Payable of $7.06 million as of 2023-09-30, per its 10-Q filed 2023-12-29.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified › Notes and Loans Payable
us-gaap:NotesAndLoansPayable · last filed 2023-12-29
- 2023-09-30: Notes and Loans Payable $7.06M.
- 2023-06-30: Notes and Loans Payable $7.03M.
- 2023-03-31: Notes and Loans Payable $6.90M.
- 2022-12-31: Notes and Loans Payable $7.15M.
| Period end | Notes and Loans Payable |
|---|---|
| 2023-09-30 | $7.06M 10-Q · filed 2023-12-29 |
| 2023-06-30 | $7.03M 10-Q · filed 2023-08-21 |
| 2023-03-31 | $6.90M 10-Q · filed 2023-05-22 |
| 2022-12-31 | $7.15M 10-Q · filed 2023-12-29 |
| 2022-09-30 | $7.24M 10-Q · filed 2022-11-21 |
| 2022-06-30 | $7.36M 10-Q · filed 2022-08-22 |
| 2022-03-31 | $7.29M 10-Q · filed 2022-05-19 |
| 2021-12-31 | $7.18M 10-K · filed 2023-04-17 |
| 2021-09-30 | $6.77M 10-Q · filed 2021-11-19 |
| 2021-06-30 | $6.66M 10-Q · filed 2021-08-23 |
| 2020-12-31 | $6.63M 10-K · filed 2022-04-14 |